Takeda’s zasocitinib shows high rates of skin clearance in phase 3 psoriasis studies
Globally, an estimated 64 million people have psoriasis, with about 80-90% of those having plaque psoriasis
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Takeda’s zasocitinib shows high rates of skin clearance in phase 3 psoriasis studies
Globally, an estimated 64 million people have psoriasis, with about 80-90% of those having plaque psoriasis
Lilly to acquire AtaiBeckley in deal worth $2.8bn
The acquisition will advance therapies for treatment-resistant depression and other mental health conditions
Almirall’s paediatric registration of Ebglyss for atopic dermatitis gets EMA acceptance
Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood
Alzheimer’s groups call for urgent global focus on women’s brain health
New op-ed published by leaders from the Women’s Alzheimer’s Movement at Cleveland Clinic, Alzheimer’s Research UK and the Alzheimer’s Association
Communiqué Awards 2026: celebrating excellence in healthcare communications
This year’s Awards, held at the Grosvenor House Hotel in London on 2 July, included 32 categories
Latest content
Richmond Pharmacology appoints Daniel Chapple as Commercial Director
Chapple has held senior leadership roles at DontBePatient Intelligence, Alira Health, Innovative Trials, Cognizant and ICON
Read More
The Bloc appoints Jon Chapman as European Executive Creative Director
Chapman previously held senior creative leadership positions at Havas Lynx, BBDO and BBH
Read More
Camena Bioscience appoints Gregory McGuinness as CEO
McGuinness was most recently CEO at Inanovate
Read More
POP Health appoints Stephanie O’Hagan as Senior Director
O’Hagan most recently spent a decade in senior leadership at Envision 90TEN
Read More
Intelligence
The UK’s life sciences’ crossroads: competing in a market defined by speed, scale and investment
The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates
Read More
Launching into an AI-powered future: a prescription for success
Making launch more effective, precise, cost-effective and agile demands new thinking and new technologies
Read More
ASCO 2026: the art of translation
Translating emerging science into care that works meaningfully in practice
Read More
Steering generative AI into the pharma fast lane
Industry needs to press the accelerator to adopt AI across functions to
supercharge launch excellence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Obesity care in the UK – why it can’t improve until it is recognised as a disease
The WHO classified obesity as a chronic disease over twenty years ago – but UK policy has yet to follow
Read More
Blogs
Latest
What do patient stories actually teach us?
July 21, 2026 | Mednet|Making Health Whole, Patient Stories, health communications, marketing strategy, medcomms
How do we translate individual experiences into support that helps others and create support that feels personal but remains relevant to many?
More Than Pink Walls: What Women-Centric Care Actually Requires
July 15, 2026 | Medscape Education|
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the …
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization
July 14, 2026 | Real Chemistry|AI, Innovation, healthcarecommunications
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
July 2, 2026 | Medscape Education|#APEX2026
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
July 1, 2026 | Medscape Education|#HearFromHer #PretermBirth
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity …
Infographic: Are data blind spots putting your launch at risk?
July 16, 2026 | Inizio|
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult …
Key takeaways from ASCO® 2026
July 16, 2026 | Inizio|
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed …
Why faster trials make participant understanding more important than ever
July 15, 2026 | Cuttsy + Cuttsy|Informed Consent, clinical trials, communication
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
July 8, 2026 | Cuttsy + Cuttsy|Digital, clinical trials, communication, design
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
July 2, 2026 | Cuttsy + Cuttsy|Patient-centricity, patient engagement
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.